Institutional investors purchased a net $34.5 thousand shares of ICCC during the quarter ended September 2013. This may signal that the smart money is gaining interest in this company as the 5.09% of the shares outstanding that institutional investors hold is among the lowest in the Medical Specialties industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
GRT CAPITAL PARTNERS LLC Bought 31.3 Thousand shares of ImmuCell Corp
UBS SECURITIES LLC Bought 1.5 Thousand shares of ImmuCell Corp
RENAISSANCE TECHNOLOGIES LLC Bought 1.0 Thousand shares of ImmuCell Corp